Development of a new diagnostic method of arthritis

The aim of this project is to validate the diagnostic value of transcriptomic and/or proteomic profiles of synovial material in early arthritis. It is based on preliminary data showing that gene expression profilesin synovial biopsiesfrom patients with arthritis are able to discriminate the samples according to the underlying disorder. The large-scale confirmation of these data during this project has been one of the keystonesfor the development of an arthritis diagnostic by the young company DNALytics.

 

Consortium

Companies: Eppendorf Array technologies (EAT), Eurogentec

Universities: ULiège, UCLouvain, Université Libre de Bruxelles, UZ Ghent

 

Contact:

Françoise De Longueville: [email protected]

Website: www.dnalytics.com